Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vitro, S.A. (VITROA) Fair Value & Analysis

Basic Materials · MX · Market cap 2.8B MXN

Price5.89 MXN
Fair Value0.9900 MXN
Upside-83.2%
Quality89/100
Evidence: Medium Range 0.7400 MXN – 1.43 MXN

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Vitro, S.A. (VITROA) currently trades at 5.89 MXN, while our model-based Fair Value estimate is 0.9900 MXN — implying the stock looks roughly 83.2% overvalued today. We read business quality at 89/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is based in San Pedro Garza García, Mexico.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Vitro, S.A. (VITROA) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 0.9900 MXN versus a price of 5.89 MXN — about −83% (overvalued). Model-based estimate, not financial advice.
What is the fair value of VITROA?
Our 21-model fair value for Vitro, S.A. is 0.9900 MXN (as of Jun 24, 2026), built from audited fundamentals. The current price is 5.89 MXN.
What is the quality score of VITROA?
Vitro, S.A. has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.